Lung Cancer Screening Roundtable| Partnership to Reduce Cancer in RI

RI Lung Cancer Screening Roundtable (3)_edited_edited.png

We are pleased to announce the RI Lung Cancer Screening Roundtable will take place

virtually on May 14, 2025 from 7:30 - 9:00 AM.

https://uri-edu.zoom.us/webinar/register/WN__kydblpxSUCQ-1mrf71IbQ#/registration

Activity Description

The Rhode Island Lung Cancer Screening Roundtable is a live, interprofessional virtual educational activity designed to improve knowledge and clinical practice related to lung cancer screening and tobacco cessation. This 90-minute session brings together primary care providers, specialists, public health professionals, and healthcare stakeholders to explore barriers to screening, effective documentation practices, and strategies to improve access and follow-up care. Through a moderated panel discussion featuring clinical experts and community health advocates, participants will learn to apply evidence-based workflows, utilize 2022 Lung-RADS coding for CT reporting, and implement smoking history documentation as part of the lung cancer screening process. This activity also addresses interdisciplinary collaboration and innovative solutions to provider shortages, such as leveraging electronic health records and care navigation. The roundtable supports statewide efforts to reduce cancer disparities and promotes best practices aligned with current national guidelines, with the goal of improving early detection and outcomes for high-risk populations.

Target Audience

Physicians, Physician Associates, Nurse Practitioners, Registered Nurses, Social Workers, Medical Assistants, Fellows, Residents, Medical & Nursing Students and other allied healthcare professionals engaged in primary care; health insurers, policymakers, public health professionals, cancer survivors and caregivers

Learning Objectives

Identify the barriers to lung cancer screening in Rhode Island.
Contrast evidence-based methods that facilitate lung cancer screening completion for eligible patients.
Describe methods to improve referral systems to pulmonology.
Classify the use of lung rads 2022 codes for lung cancer screening CT reporting and recommendations.
Summarize the impact that smoking cessation can have on cancer incidence and mortality.

Jointly Provided by:

Accreditation

In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP CME Credit

The AAFP has reviewed RI Lung Cancer Screening Roundtable and deemed it acceptable for up to 1.50 Live AAFP Elective credit(s). Term of Approval is from 05/14/2025 to 05/14/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associates/ Nurse Practitioners

Participants will receive a Certificate of Attendance stating this program is designated for 1.5 hours AMA PRA Category 1 Credits™. This credit is accepted by the AAPA and AANP.

Nursing Continuing Professional Development

This nursing continuing professional development activity was approved by The University of Rhode Island which is approved as a provider (#5-173) of nursing continuing professional development by the Northeast Multistate Division Education Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses will be awarded 1.5 contact hour. Expiration Date: May 14, 2026.

Social Workers

This activity has been submitted to the RI Chapter of the National Association of Social Workers Rhode Island Chapter for 1.5 credit hour. NASW Authorization # RI-9925. Expiration Date: 4/30/2027

Interprofessional Continuing Education (IPCE)

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Support

This program is supported in part by Cooperative Agreement Number NU58DP007118, funded by the Centers for Disease Control and Prevention and awarded to the Rhode Island Department of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the Department of Health and Human Services, or the Rhode Island Department of Health. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc, University of Rhode Island College of Pharmacy, and the Partnership to Reduce Cancer in Rhode Island.

Disclosure & Conflict of Interest Policy

University of Rhode Island College of Pharmacy, the Partnership to Reduce Cancer in Rhode Island and Medical Learning Institute Inc are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.

Faculty Disclosures

Terrance Healey, MD - Rhode Island Medical Imaging - has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Hina Khan, MD - Brown Health - has a financial interest/relationship or affiliation in the form of:

The following relationships have ended within the last 24 months:

Advisory Board: Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Regeneron

Paul Larson, MD, MBA - Brown Health Primary Care - has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Andrew Foderaro, MD - Brown Health - has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Robert Smith, PhD - American Cancer Society - has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Cheryl Ferreira, BSN-RN, BA, BS - has no relevant financial relationships with ineligible companies to disclose for this educational activity.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute Inc, University of Rhode Island College of Pharmacy, and the Partnership to Reduce Cancer in Rhode Island do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation and Program Evaluation

All participants will have the opportunity to evaluate the educational sessions, speakers and identify educational needs.

There are no fees for participating in or receiving credit for this CE activity, however, registration is required. In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation, and your certificate of credit will be emailed to you within 4-weeks. Further Instructions and a QR code will be provided at the end of this live activity.

Nurses and social workers must complete a program evaluation at www.uripharmacycpd.org within 60 days of the live program date (5/14/2025) in order to receive CE credit. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit. Social Workers and Nurses can print CE statements from their account profile. Physicians will receive the official CE statement via email after they have completed the program evaluation.

You will receive your nurse, social worker, or attendance certificate from University of Rhode Island College of Pharmacy, and the Partnership to Reduce Cancer in Rhode Island. If you have questions regarding this certificate, please contact pharmce@etal.uri.edu.

You will receive your physician ACCME or physician AAFP certificate from Medical Learning Institute Inc. If you have questions regarding this certificate, please contact mvu@mlieducation.org.

For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.

About This Activity

Medical Learning Institute Inc, University of Rhode Island College of Pharmacy, and the Partnership to Reduce Cancer in Rhode Island are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.